Replies to post #25066 on Cel Sci Corporation (CVM)

[Charmed7713]

One further thing about dropout rates....Ergomed markets themselves based on low lost to follow up rates on their own website. Cel-Sci is paying extra to them to track patients. Ergomed has 12 million in a phase 3 drug that can become standard of care in a market that hasnt seen any positive changes on 60+ years. I dont believe they will knowingly have dropout rates in double digits. Just my thoughts...